ArticleGMS hygiene and infection control2025
Spinal tuberculosis treatment duration: Correlating MRI findings with therapeutic outcomes.
Article in GMS hygiene and infection control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical and imaging factors associated with paraplegia at presentation in thoracic spinal tuberculosis.International orthopaedics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Tuberculosis (TB) of the spine is the most common form of musculoskeletal TB, especially in developing countries, and may lead to serious complications if untreated. Early diagnosis, anti-tubercular therapy (ATT), and surgery when needed are key to effective management. Magnetic resonance imaging (MRI) is the most reliable tool for diagnosis, monitoring, and determining treatment duration. This study aims to evaluate the appropriate length of ATT and MRI's role in guiding therapy in spinal TB. Methods: This 36-month prospective study included 100 spinal TB patients treated with standard ATT. Clinical, hematological, and MRI evaluations guided therapy duration. Biopsy confirmed diagnosis, and surgery was done when indicated. MRI healing was classified as complete, partial, or non-healed. ATT continued until MRI confirmed healing. Multidrug-resistant cases received second-line therapy. Results: In a cohort of 100 spinal tuberculosis patients (mean age 23.5 years), 70% were female, and 88% had category-1 TB, with 12% exhibiting multidrug resistance. The thoracic spine was most affected (64%), followed by lumbar (30%) and cervical (6%) regions. Conservative treatment was administered to 78 patients, while 22 underwent surgery. Neurological deficits were present in 78% of cases. Diagnostic yields were highest with histopathology (50%), followed by GeneXpert (48%), smear microscopy (30%), and culture (28%). Inflammatory markers showed significant improvement: equivalent series resistance decreased from 34.95 to 13.1 mm/hr, and C-reactive protein from 32.4 to 6.3 mg/L over 12 months. MRI assessments revealed complete healing in 30% at 6 months and 80% at 12 months. By 18 months, recovery rates reached 89% clinically, 82% hematologically, and 88% radiologically. Conclusion: Clinical recovery occurs first, but MRI is the most reliable tool for determining antitubercular therapy duration in spinal TB due to its accuracy in assessing disease resolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.